Algorithm predicts ovarian cancer in BRCA1/2 carriers within NHS
A screening tool for women with BRCA1 or 2 variants identifies ovarian cancers at an earlier stage, and reduces the need for expensive cancer therapies...
A screening tool for women with BRCA1 or 2 variants identifies ovarian cancers at an earlier stage, and reduces the need for expensive cancer therapies...
by BioNews
Researchers have developed a blood test that can accurately detect ovarian cancer in women with a growth in their pelvis...
Researchers have developed a simple test that could be used to screen women with suspected endometrial cancer and reduce the need for more invasive diagnostic methods...
The scope of DNA and genetic testing can be an extremely complicated and difficult topic for the average person without a scientific degree to understand. It has become much more accessible since genomic sequencing became cheaper and genetic testing is now deployed in a wide range of health settings...
Hundreds of inherited mutations to BRCA1, a high-risk susceptibility gene for breast and ovarian cancer, have been shown to be harmless...
A genetic predisposition to endometriosis may also increase a woman's risk of developing certain types of ovarian cancer, new findings suggest...
Cells in cervical smear test samples could be used as an indicator for breast and ovarian cancer, and show promise as tools for monitoring cancer risk...
Mutations in the FANCI gene have been linked to risks of ovarian cancer for the first time...
Sarah Norcross, director of the Progress Educational Trust, invited the audience of the event to consider where assisted reproductive technologies stood 55 years ago...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.